Nikita Sanati Morel

Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression.

BMC Medical Education April 9, 2026 Nikita Sanati Morel, Dea Siggaard Stenbæk, Johan Lundberg et al.

Major depression is a prevalent condition among patients with life-threatening illnesses, such as cancer, and recent findings suggest that psilocybin may hold promising treatment potential. Contemporary trials of psilocybin generally employ a model that includes psychotherapeutic support consisting of preparation and integration sessions surrounding the dosing. However, there is limited...